请拖入内容到容器
请拖入内容到容器

Category one

Category two

Category three

请拖入内容到容器
Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
2019 CPHI Exhibition in India
Abstract:
2019 CPHI Exhibition in India
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
Abstract:
The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some extra incentives.
2019 CHPI Exhibition in Shanghai
请拖入内容到容器

首页联系方式

Shandong Sihuan Pharmaceutical Co.,Ltd.
Add :Nanyuan Road, Economic Development Zone,Pingyuan County, Dezhou City,Shandong Province, China. 
 
Tel:+86-531-89702887 +86-531-88993983 +86-531-88993893
Fax:+86-531-89702886 

Webpage Copyright:Shandong Sihuan Pharmaceutical Co.,Ltd.  |  ICP Register No.: 鲁ICP备17046678号-1 | Powered by www.300.cn JINAN

请拖入内容到容器
Search